Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy [2] (multiple letters)

Archives of Neurology

Volumn 61, Issue 8, 2004, Pages 1328-1329

  Grunewald, R A ^b   Salas Puig, J ^b   Genton, P ^b   Panayiotopoulos, C P ^b   Prasad, A ^b   Kuzniecky, R I ^b   Knowlton, R C ^b   Welty, T E ^b   Martin, R C ^b   Mendez, M ^b   Faught, R E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

CLINICAL FEATURE; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOLERABILITY; HUMAN; LETTER; LONG TERM CARE; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; SIDE EFFECT; TENDON REFLEX;

ANTICONVULSANTS; DRUG THERAPY, COMBINATION; HUMANS; MYOCLONIC EPILEPSY, JUVENILE;

EID: 4043158580     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)